Skip to content
  • North caroline 1207, east harbal road , Canada
  • [email protected]
  • About
    • Firm
    • Team
    • Values
  • Services
    • M&A Advisory
    • Capital Raising
    • Debt Advisory & Restructuring
    • Merchant Banking
  • Industries
  • Transactions
  • Insights & News
    • Podcast
    • Management Interviews
    • Market Insights
    • INFOR Press Releases
  • Contact
  • P
  • T
  • in

HLS Therapeutics Presentation with CEO Gregory Gubitz and President & COO Gilbert Godin

  • Home
  • Interview
  • HLS Therapeutics Presentation with CEO Gregory Gubitz and President & COO Gilbert Godin
  • 22 September 2020
  • By akoval
  • Interview
https://www.youtube.com/watch?v=bmPICxXiIbA
  • Share:
Previous Post

ECN Capital Announces Closing of $75 Million Offering of 6.00% Senior Unsecured Debentures

Next Post

WeedMD Enters into Binding Term Sheet for $30 Million Credit Facility with LiUNA Pension Fund and Changes Filing Date of Second Quarter 2020 Financials to September 30, 2020

Recent articles

  • Dentalcorp Announces Closing of Acquisition by Investment Funds Affiliated with GTCR
  • Wellington-Altus announces nearly $400M strategic minority investment from leading private equity firm Kelso & Company, confirming $1.5B+ valuation
  • Ex-Lundin CEO Rockandel Joining INFOR to Seize on Mining Deals
  • INFOR Financial Inc. Opens the Market
  • Tudor Gold Announces Binding Letter of Intent to Acquire American Creek

Innovative, Forward-Thinking Financial Advice

Legal and Regulatory

  • Privacy Policy
  • Terms of Use
  • Regulatory Disclosures

Subscribe

Sign up to receive the INFOR Financial podcast, management interviews and market insights


    This site is protected by reCAPTCHA and the Google
    Privacy Policy and
    Terms of Service apply.

    Contact

    Royal Bank Plaza,
    South Tower

    200 Bay Street, Suite 2350
    Toronto, ON M5J 2J2

    E[email protected]
    P(416) 646-2660
    F(416) 981-7033

    © 2026 All Right Reserved By INFOR Financial Group Inc.